Posts Topics Forums Images
Search videos from message boards Videos Search messages from microblogs Microblogs Search messages from imdb.com Imdb Search messages from yuku.com Yuku Search messages from lefora.com (free forums) Lefora
My account: Login | Sign Up
Loading... 

CELG: Message Board for Celgene Corporation | Forum profile

Forum profile page for CELG: Message Board for Celgene Corporation on http://www.investorvillage.com. This report page is the aggregated overview from a single forum: CELG: Message Board for Celgene Corporation , located on the Message Board at http://www.investorvillage.com. This forum profile page summarizes the general forum statistics such as: Users Activity, Forum Activity, and Top Authors, which are reported in either a table or graph below for a given reporting time period. Additional forum profile information for "CELG: Message Board for Celgene Corporation " on the Message Board at http://www.investorvillage.com is also shown in the following ways:

1) Latest Active Threads
2) Hot Threads for Last Week

Warning: These statistics are generated using 'best efforts' and can experience delays and reporting errors at times. Please note that such statistics do not constitute a forum's popularity and/or exact posting volumes at any given reporting period.

Site: InvestorVillage: Stock Message Boards - CELG: Message Board for Celgene Corporation (site profile, domain info investorvillage.com)
Title: CELG: Message Board for Celgene Corporation
Url: http://www.investorvillage.com/smbd.asp?mb=341&...
Users activity: 1 post per thread
Forum activity: 193 active threads during last week
 

Posting activity on CELG: Message Board for Celgene Corporation :

  Week Month 3 Months
Threads: 193 562 905
Post: 193 563 907
 

CELG: Message Board for Celgene Corporation Posting activity graph:

Posts by:  day  week  month 

Top authors during last week:

Name
Posts
Rob Cos
38
user's latest post:
Dec 1 Journal of Clinical...
Published (2009-11-25 19:07:00)
  Journal of Clinical Oncology , Vol 27, No 34 (December 1), 2009: pp. 5676-5677 2009 American Society of Clinical Oncology.   EDITORIALS   Relapse/Refractory Myeloma Patient: Potential Treatment Guidelines   Jes?s F. San Miguel   Servicio de Hematolog?a. Hospital Universitario de Salamanca, Centro de Investigaci?n del C?ncer Instituto de Biologia Molecular y Celular del Cancer/CSIC, Universidad de...
Kokopoppy
25
user's latest post:
20,000 shares for sale at...
Published (2009-11-25 15:38:00)
tocentsworth
15
user's latest post:
Somehow, TCW Group's...
Published (2009-11-25 13:18:00)
If you go to the very last Institutional Holdings page for Celgene as of 9-30-09, at nasdaq.com , you will see that TCW Group, Inc. reduced its third quarter Celgene holdings to zero (0) shares, from 1,553,530 shares at the end of the second quarter. According to my calculations, this put it in third place as a Celgene "net seller" (i.e. net reduction in shares):   Janus Capital...
put_lipstick_on_this_pig
9
user's latest post:
Good day!!...Happy Thanksgiving...
Published (2009-11-25 16:00:00)
Doolen
8
user's latest post:
Happy Thanksgiving all | CELG...
Published (2009-11-25 14:43:00)
Signing off for the holiday. Lots to be grateful for ... From the country we live in ... To those at risk protecting us ... To family ... To football ... To having enough to merit following the market ... All the best.
celgup
6
user's latest post:
So at what point to you (Citi)...
Published (2009-11-19 12:18:00)
This practice of taking everything off the board and not adding even a heavily discounted value for pipeline into the target price has got to stop.  Heaven forbid if you put a target price out there that may have so real connection to the existing and pipeline value, you'd have to be considerably higher than the current price and we can't have that. Problem seems to be that these firms have been so snake bit in the last...
neednews
6
user's latest post:
Merrill Lynch ASH preview | CELG...
Published (2009-11-24 11:53:00)
CELG’s MM-015 Revlimid study a key focus The American Society of Hematology meeting will take place on Dec 5-8. We expect the MM-015 Phase 3 study of Revlimid in front-line multiple myeloma to be the key presentation for CELG. Although there has been investor controversy heading into this data presentation, we continue to expect positive results based on our statistical analysis (published Nov 9). We look for progression free...
mergerman
6
user's latest post:
ot: is bear rally over? | CELG...
Published (2009-11-25 15:24:00)
  Guess the bear market rally wasnt over Sept 1. "Bear Rally" - what a joke. And the pompous attitude about it is annoying.   Wait for that next down 150+ Dow day for reasonable to return.   Bear Market Rally. He He _____________________________   Original Message (# 138852) by reasonable_risk on 9/1/2009 11:04:48 AM ot: is bear rally over? some think so ... prechter goes 100% short positioned for...
grafzeppelin
6
user's latest post:
"The increase in CD154...
Published (2009-11-25 06:24:00)
another demo of imids=immunomodulatory=good! msg 140912
JBWIN
6
user's latest post:
Building IP: Patent Application...
Published (2009-11-26 12:58:00)
  Celgene gains two exclusive worldwide licenses for major new class of drug targets June 7, 2001 Celgene Corporation (Warren, NJ) announced today that it has significantly expanded its intellectual property estate and its portfolio of novel drug targets through exclusive worldwide license agreements with three leading research institutions—New York University School of Medicine, the Research Foundation of the State...
 

Latest active threads on CELG: Message Board for Celgene Corporation ::

No activity within last 3 months.

 

Hot threads for last week on CELG: Message Board for Celgene Corporation ::

No active threads for last week.

This page was found by:   celgene forum  celgene message board   celg rob cos